Transcriptional Checkpoints Of Autoimmune Encephalomyelitis
Transcriptional Checkpoints Of Autoimmune Encephalomyelitis
批准号:
10521303
负责人:
MARTHA S JORDAN
金额:
$50.12万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-12-20 至 2024-11-30
关键词:
AccelerationAnimal ModelAnimalsAntigensArthritisAutoimmune DiseasesAutoimmune ResponsesBindingBiochemicalBiologyCeliac DiseaseCell Differentiation processCell physiologyCellsCentral Nervous System DiseasesChIP-seqClinical ManagementColitisDNADevelopmentDiseaseDisease ProgressionDrug TargetingExperimental Autoimmune EncephalomyelitisFDA approvedFamilyGenesGeneticGenetic TranscriptionGoalsHealthHumanImmune responseImmunologicsInfectionInflammatoryInterferonsKnock-outKnockout MiceKnowledgeKnowledge ManagementLegal patentLymphoidLymphoid CellMediatingModelingMultiple SclerosisMusMyelinMyelogenousMyeloid CellsNuclearPathologicPatientsPersonsPharmaceutical PreparationsPharmacologic SubstancePharmacotherapyPlayPsoriasisRecoveryRegulatory T-LymphocyteRelapseReportingResearch ProposalsResistanceRheumatoid ArthritisRisk FactorsRoleSmall Interfering RNAT-LymphocyteTestingTherapeuticTimeUlcerative ColitisUnited StatesVirulence Factorsautoimmunity checkpointcell typeexperiencegenome wide association studygenome-wideinhibitormembermultiple sclerosis patientmultiple sclerosis treatmentnovelperipheral bloodpreventprimary sclerosing cholangitissmall moleculetheoriestherapeutically effectivetime use
中文摘要
本研究计划的总体目标是阐明一种新的病理机制
英文摘要
The overall objective of this research proposal is to elucidate a new pathological mechanism
underlying autoimmune diseases such as multiple sclerosis (MS) and to test a new class of
therapeutic compounds in models of MS. The proposal is inspired by two lines of recent
discoveries: (i) in humans, several genome-wide association studies independently established
that c-Rel, the lymphoid and myeloid member of the Rel/nuclear factor-kB (Rel/NF-kB) family, is
a risk factor for six autoimmune diseases including MS; (ii) in mice, c-Rel deficiency renders them
resistant to autoimmune encephalomyelitis, arthritis, and colitis while having limited impact on
infections. We therefore theorized that c-Rel is both a risk factor and a pathogenic factor for
human autoimmune diseases and that drugs targeting it should be effective for treating the
diseases. To test this theory, we have developed a new class of small molecules that specifically
inhibits c-Rel function by preventing its binding to DNA. In mice, these compounds are highly
effective in suppressing autoimmune responses and in ameliorating ongoing experimental
autoimmune encephalomyelitis, an animal model for MS. The specific goals of this proposal are
to elucidate the mechanism(s) through which c-Rel controls autoimmune encephalomyelitis, and
to test the theory that inhibition of c-Rel in both inflammatory and regulatory T cells is required to
cure autoimmune encephalomyelitis. Specifically, we will test the hypotheses that (i) c-Rel serves
as a transcriptional checkpoint of autoimmune encephalomyelitis; (ii) c-Rel controls autoimmune
encephalomyelitis in a cell- and gene-specific manner; and (iii) c-Rel blockade diminishes anti-
myelin immune responses of multiple sclerosis patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of SLP-76 phosphorylation in T cell development
-
批准号:7270073
-
项目类别:
-
资助金额:$12.76万
-
财政年份:2006
-
负责人:MARTHA S JORDAN
-
依托单位:
The role of SLP-76 phosphorylation in T cell development
-
批准号:7485035
-
项目类别:
-
资助金额:$12.76万
-
财政年份:2006
-
负责人:MARTHA S JORDAN
-
依托单位:
The role of SLP-76 phosphorylation in T cell development
-
批准号:8123426
-
项目类别:
-
资助金额:$12.76万
-
财政年份:2006
-
负责人:MARTHA S JORDAN
-
依托单位:
The role of SLP-76 phosphorylation in T cell development
-
批准号:7147801
-
项目类别:
-
资助金额:$12.76万
-
财政年份:2006
-
负责人:MARTHA S JORDAN
-
依托单位:
The role of SLP-76 phosphorylation in T cell development
-
批准号:7660322
-
项目类别:
-
资助金额:$12.76万
-
财政年份:2006
-
负责人:MARTHA S JORDAN
-
依托单位:
Notch Regulation of Hematopoietic Cell Fates
-
批准号:10335128
-
项目类别:
-
资助金额:$45.5万
-
财政年份:2000
-
负责人:MARTHA S JORDAN
-
依托单位:
海外基金